(19)
(11) EP 2 479 182 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.07.2016 Bulletin 2016/28

(45) Mention of the grant of the patent:
25.05.2016 Bulletin 2016/21

(21) Application number: 10817185.1

(22) Date of filing: 15.09.2010
(51) International Patent Classification (IPC): 
C07H 19/067(2006.01)
C07F 9/6558(2006.01)
C07F 9/6584(2006.01)
C07H 19/167(2006.01)
C07H 21/02(2006.01)
C07F 7/18(2006.01)
C07F 9/6561(2006.01)
C07H 19/10(2006.01)
C07H 19/20(2006.01)
C07C 43/13(2006.01)
(86) International application number:
PCT/JP2010/065900
(87) International publication number:
WO 2011/034072 (24.03.2011 Gazette 2011/12)

(54)

NOVEL PROTECTING GROUP FOR SYNTHESIZING RNA AND DERIVATIVE THEREOF

NEUE SCHUTZGRUPPE FÜR SYNTHESE VON RNA UND DERIVAT DARAUS

NOUVEAU GROUPE PROTECTEUR POUR SYNTHÉTISER DE L'ARN ET DÉRIVÉ DE CELUI-CI


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 16.09.2009 US 242877 P

(43) Date of publication of application:
25.07.2012 Bulletin 2012/30

(73) Proprietor: Wave Life Sciences Japan, Inc.
Kagoshima-shi Kagoshima 891-1394 (JP)

(72) Inventors:
  • WADA Takeshi
    Kashiwa-shi Chiba 277-0852 (JP)
  • SHIMIZU Mamoru
    Kashiwa-shi Chiba 277-0885 (JP)

(74) Representative: Godemeyer Blum Lenze Patentanwälte Partnerschaft mbB - werkpatent 
An den Gärten 7
51491 Overath
51491 Overath (DE)


(56) References cited: : 
EP-A1- 1 795 536
WO-A1-2005/023828
WO-A1-2006/022323
DD-A1- 133 885
WO-A1-2004/085494
WO-A1-2005/092909
WO-A1-2007/064291
US-A- 4 542 142
   
  • ZHANG ET AL: "Asymmetric synthesis of novel alpha-amino acids with beta-branched side chains", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 17, no. 9, 3 April 2007 (2007-04-03), pages 2401-2403, XP022015312, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2007.02.041
  • KIM S-G ET AL: "Use of the hexafluoro-2-butyl protecting group in the synthesis of DNA fragments via the phosphoramidite approach on solid supports", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 5, no. 15, 3 August 1995 (1995-08-03) , pages 1663-1666, XP004135404, ISSN: 0960-894X, DOI: 10.1016/0960-894X(95)00269-Y
  • Kenji Uneyama ET AL: "BISTRIFLUOROMETHYLATION OF ACRYLAMIDE FOR TRIFLUOROMETHYLATED SYNTHETIC BLOCKS", Tetrahedron Letters,, vol. 30, no. 1, 1 January 1989 (1989-01-01), pages 109-110, XP055108110,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).